In August 2024, Metsera, a newly launched clinical-stage biopharmaceutical company, emerged with a significant US$ 290 million in funding to develop innovative treatments for obesity and metabolic diseases, particularly focusing on GLP-1 receptor agonists
Glutathione is often referred to as the "master antioxidant" due to its remarkable ability to combat oxidative stress
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials
Furthermore, they reported a lower incidence of adverse effects in the ALC group compared with the antidepressant group
The combination can leave food sitting in your stomach far longer than comfortable, creating that heavy, nauseated feeling